Bubba Kush X Purple Punch 20 by Nutty North Genetics
Bubba Kush × Purple Punch 2.0
Developed by Nutty North Genetics, Bubba Kush X Purple Punch 2.0 is an indica-dominant hybrid that merges the qualities of Bubba Kush and Purple Punch. This strain is recognized for its robust characteristics and appealing sensory profile, making it a notable contemporary cultivar.
Appearance
This hybrid presents dense, compact buds featuring a multi-layered structure. The coloration includes deep greens with noticeable purple hues and vibrant orange pistils. An abundant trichome coverage gives the buds a frosted, sparkling appearance and a sticky texture, indicative of high resin content.
Aroma & Flavor
The aroma is a complex blend, starting with earthy pine and hash notes, overlaid by sweet, fruity scents reminiscent of grape and berry, with a subtle skunk undertone. On the palate, deep earthy flavors are complemented by sweet, citrusy, and berry notes, leading to a smooth, creamy finish with a hint of spice on the exhale.
Effects
Users often report experiencing a sense of calm and a tingling sensation. The strain is generally associated with deeply relaxing effects, drawing from its indica heritage.
Terpenes & Cannabinoids
Key terpenes identified include Myrcene, Limonene, and Caryophyllene, contributing to the strain's aroma and potential effects. Laboratory analysis indicates THC levels typically range between 20% and 25%, with some phenotypes potentially exceeding 25%, while CBD content remains below 1%.
Growing
The strain exhibits robust growth patterns and a sturdy, bushy structure, with fast flowering times influenced by its Purple Punch lineage. Its compact bud formation is well-suited for indoor cultivation, and the buds show resilience in various environmental conditions.
Origins & Lineage
Bubba Kush X Purple Punch 2.0 was developed by Nutty North Genetics, combining the indica-dominant Bubba Kush, known for its resin production and relaxing effects, with Purple Punch, recognized for its sedative qualities and fruity profile. The development began around 2018, utilizing advanced genetic mapping for consistency.